CytomX Therapeutics Inc (CTMX)
1.98
-0.06
(-2.94%)
USD |
NASDAQ |
May 10, 16:00
1.92
-0.06
(-3.03%)
After-Hours: 20:00
CytomX Therapeutics Cash from Financing (Quarterly): 0.244M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.244M |
| September 30, 2023 | 29.67M |
| June 30, 2023 | 0.317M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.19M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.451M |
| March 31, 2022 | 0.007M |
| December 31, 2021 | 0.683M |
| September 30, 2021 | 0.104M |
| June 30, 2021 | 0.691M |
| March 31, 2021 | 108.74M |
| December 31, 2020 | 13.02M |
| September 30, 2020 | 0.167M |
| June 30, 2020 | 1.548M |
| March 31, 2020 | 2.157M |
| December 31, 2019 | 0.401M |
| September 30, 2019 | 0.063M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.698M |
| March 31, 2019 | 0.465M |
| December 31, 2018 | 0.724M |
| September 30, 2018 | 135.58M |
| June 30, 2018 | 0.722M |
| March 31, 2018 | 2.602M |
| December 31, 2017 | 21.08M |
| September 30, 2017 | 1.16M |
| June 30, 2017 | 0.666M |
| March 31, 2017 | 0.891M |
| December 31, 2016 | 0.501M |
| September 30, 2016 | 0.251M |
| June 30, 2016 | 0.208M |
| March 31, 2016 | 0.036M |
| December 31, 2015 | 82.65M |
| September 30, 2015 | -3.182M |
| June 30, 2015 | 73.10M |
| March 31, 2015 | 0.835M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
108.74M
Maximum
Mar 2021
8.376M
Average
0.401M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Amgen Inc | -1.708B |
| Ocular Therapeutix Inc | 321.22M |
| Bristol-Myers Squibb Co | 14.64B |
| ACADIA Pharmaceuticals Inc | 1.043M |
| Calidi Biotherapeutics Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.96M |
| Cash from Investing (Quarterly) | 12.87M |
| Free Cash Flow | -56.88M |
| Free Cash Flow Per Share (Quarterly) | -0.2726 |
| Free Cash Flow to Equity (Quarterly) | -22.23M |
| Free Cash Flow to Firm (Quarterly) | -22.23M |
| Free Cash Flow Yield | -38.90% |